humans |
83 |
male |
59 |
adult |
58 |
female |
53 |
middle aged |
49 |
medical sciences |
45 |
aged |
31 |
hong kong |
27 |
adolescent |
26 |
covid-19 |
25 |
gastric cancer |
24 |
animals |
20 |
child |
19 |
aged, 80 and over |
17 |
colorectal cancer |
17 |
survival analysis |
17 |
child, preschool |
16 |
dna methylation |
16 |
epidemiology |
16 |
gastroenterology |
16 |
china |
15 |
cross-sectional studies |
15 |
gene expression |
15 |
hong kong - epidemiology |
15 |
immunohistochemistry |
15 |
molecular sequence data |
15 |
sars-cov |
15 |
asian continental ancestry group |
14 |
base sequence |
14 |
body mass index |
14 |
chinese |
14 |
colonoscopy |
14 |
complications |
14 |
coronavirus infection |
14 |
gene expression regulation, neoplastic |
14 |
health outcomes |
14 |
helicobacter pylori |
14 |
prevalence |
14 |
sars-cov-2 |
14 |
cohort studies |
13 |
double-blind method |
13 |
immune activation |
13 |
incidence |
13 |
intestine |
13 |
prognosis |
13 |
reference values |
13 |
replication |
13 |
rhizopus microsporus |
13 |
species index: fungi |
13 |
amino acid sequence |
12 |
body height |
12 |
cell line, tumor |
12 |
dna, neoplasm - genetics |
12 |
elderly |
12 |
hepatocellular carcinoma |
12 |
prospective studies |
12 |
tumor cells, cultured |
12 |
adenocarcinoma |
11 |
blotting, western |
11 |
gastric adenocarcinoma |
11 |
gene silencing |
11 |
inflammatory bowel disease |
11 |
mice |
11 |
mutation |
11 |
neoplasm proteins - genetics - metabolism |
11 |
neoplasm staging |
11 |
promoter regions, genetic |
11 |
stomach neoplasms - genetics - metabolism |
11 |
treatment outcome |
11 |
advanced hcc |
10 |
advanced hepatocellular carcinoma |
10 |
arhgap fusions |
10 |
biobank |
10 |
cpg islands |
10 |
drug screening |
10 |
ebv genome |
10 |
epigenetics |
10 |
heterogeneity |
10 |
methylation |
10 |
organoid culture |
10 |
rhoa mutations |
10 |
rna, messenger - metabolism |
10 |
sorafenib |
10 |
transcriptome sequencing |
10 |
whole-exome sequencing |
10 |
arginine methylation |
9 |
aspirin |
9 |
atrial fibrillation |
9 |
cadherins - genetics - metabolism |
9 |
cancer stemness |
9 |
codon - genetics |
9 |
e-cadherin |
9 |
gastrointestinal bleeding |
9 |
hcc |
9 |
helicobacter infections - complications |
9 |
lymphatic metastasis |
9 |
reverse transcriptase polymerase chain reaction - methods |
9 |
tumor-initiating cells |
9 |
adiponectin |
8 |
adiponectin - blood |
8 |
adverse events |
8 |
antibiotics |
8 |
carcinoma, hepatocellular - mortality - therapy |
8 |
chemoembolization, therapeutic - adverse effects - mortality |
8 |
chemoprevention |
8 |
chemotherapy |
8 |
child-pugh a |
8 |
child-pugh b |
8 |
colonic neoplasms - genetics - metabolism - pathology |
8 |
cytology and histology |
8 |
dna mutational analysis |
8 |
enzyme-linked immunosorbent assay |
8 |
gene expression profiling |
8 |
genome, viral |
8 |
hepatitis |
8 |
immunoenzyme techniques |
8 |
infusions, intra-arterial |
8 |
intestinal metaplasia |
8 |
liver neoplasms - mortality - therapy |
8 |
magnetic resonance imaging |
8 |
mice, transgenic |
8 |
nasopharyngeal carcinoma |
8 |
neoplasm invasiveness |
8 |
oncology medical sciences |
8 |
phylogeny |
8 |
point mutation - genetics |
8 |
proto-oncogene proteins - genetics |
8 |
radiology and nuclear medicine pharmacy and pharmacology biology |
8 |
reverse transcriptase polymerase chain reaction |
8 |
risk factors |
8 |
sequence analysis, dna |
8 |
time factors |
8 |
transarterial chemoembolization |
8 |
transfection |
8 |
tumor markers, biological - blood |
8 |
adenocarcinoma - genetics |
7 |
apoptosis |
7 |
body composition - physiology |
7 |
carrier proteins - genetics |
7 |
cell proliferation |
7 |
china - epidemiology |
7 |
chiroptera - virology |
7 |
colon cancer |
7 |
common cold - genetics |
7 |
coronavirus 229e, human - genetics - physiology |
7 |
coronavirus infections - genetics |
7 |
diagnosis |
7 |
disease progression |
7 |
dna primers |
7 |
down-regulation |
7 |
down-regulation - physiology |
7 |
in situ hybridization |
7 |
infant |
7 |
interval cancer |
7 |
intra-abdominal fat - physiopathology |
7 |
longitudinal studies |
7 |
macrophages - physiology |
7 |
microsatellite repeats - genetics |
7 |
obstructive sleep apnea |
7 |
oligonucleotide array sequence analysis |
7 |
predictive value of tests |
7 |
promoter regions, genetic - genetics |
7 |
risk assessment |
7 |
rna, neoplasm - metabolism |
7 |
sars virus - classification - genetics - isolation & purification |
7 |
sars virus - genetics - physiology |
7 |
severe acute respiratory syndrome - genetics |
7 |
sleep apnea, obstructive - diagnosis - physiopathology |
7 |
subcutaneous fat, abdominal - physiopathology |
7 |
sympathetic activity |
7 |
sympathetic nervous system - physiopathology |
7 |
tumor markers, biological - analysis |
7 |
up-regulation |
7 |
viral proteins - blood - genetics |
7 |
adenocarcinoma - genetics - metabolism - pathology |
6 |
adenocarcinoma - metabolism |
6 |
adenoma - genetics - metabolism - pathology |
6 |
age factors |
6 |
alkaline phosphatase |
6 |
antimetabolites, antineoplastic - pharmacology |
6 |
antipsychotic agents - therapeutic use |
6 |
bevacizumab |
6 |
biliary |
6 |
biopsy |
6 |
blood pressure |
6 |
body weight |
6 |
carcinoma |
6 |
cell transformation, neoplastic - genetics |
6 |
children |
6 |
cholangiogram |
6 |
colon carcinogenesis |
6 |
colon neoplasms |
6 |
colorectal cancer genes |
6 |
colorectal neoplasms - genetics |
6 |
curative colectomy |
6 |
dabigatran |
6 |
dibenzothiazepines - therapeutic use |
6 |
disease models, animal |
6 |
dna-binding proteins |
6 |
dna-binding proteins - metabolism |
6 |
drug therapy, combination |
6 |
early-onset colon cancer |
6 |
erlotinib |
6 |
follow up |
6 |
gene expression regulation, neoplastic - drug effects |
6 |
hospitalization |
6 |
intracellular signaling peptides and proteins |
6 |
ketamine |
6 |
magnetic resonance cholangiography |
6 |
microsatellite repeats |
6 |
polymerase chain reaction - methods |
6 |
proto-oncogene proteins c-bcl-2 |
6 |
psychotic disorders - drug therapy |
6 |
recurrence |
6 |
rivaroxaban |
6 |
rna, messenger - genetics |
6 |
rna, messenger - genetics - metabolism |
6 |
sorafenib-refractory |
6 |
stomach |
6 |
stomach - pathology |
6 |
stomach cancer |
6 |
stomach neoplasms - genetics |
6 |
substance abuse |
6 |
tumor markers, biological - genetics - metabolism |
6 |
ulcerative colitis |
6 |
warfarin |
6 |
young adult |
6 |
adaptor proteins, signal transducing |
5 |
adenocarcinoma - blood - diagnosis |
5 |
adenocarcinoma - diagnosis - genetics - mortality |
5 |
adenocarcinoma - genetics - metabolism |
5 |
aging |
5 |
alpha-fetoprotein |
5 |
angiotensin-converting enzyme inhibitors |
5 |
anti-bacterial agents - pharmacology - therapeutic use |
5 |
anti-ulcer agents - therapeutic use |
5 |
anticoagulant |
5 |
azacitidine - analogs & derivatives - pharmacology |
5 |
bacteria |
5 |
base pair mismatch |
5 |
bleeding |
5 |
brain neoplasms - genetics - metabolism - pathology |
5 |
breath tests |
5 |
cadherins - blood |
5 |
cancer incidence |
5 |
cancer risk |
5 |
carbon isotopes - diagnostic use |
5 |
carcinoma, hepatocellular - diagnosis - mortality |
5 |
carrier proteins |
5 |
carrier proteins - genetics - metabolism |
5 |
case-control studies |
5 |
caspase 3 |
5 |
caspases - metabolism |
5 |
cell division - drug effects |
5 |
cell line |
5 |
china - ethnology |
5 |
cholesterol - blood |
5 |
chromosome deletion |
5 |
clarithromycin - pharmacology - therapeutic use |
5 |
clinical trials |
5 |
clopidogrel |
5 |
cohort analysis |
5 |
colonic neoplasms |
5 |
colonic neoplasms - genetics - metabolism |
5 |
comorbidity |
5 |
cpg islands - genetics |
5 |
crohn's disease |
5 |
dose-response relationship, drug |
5 |
down-regulation - drug effects |
5 |
dyspepsia |
5 |
endoscopic retrograde cholangiopancreatography |
5 |
endoscopic sphicterotomy |
5 |
endothelial growth factors - metabolism |
5 |
epigenesis, genetic |
5 |
esomeprazole |
5 |
fecal-to-oral transmission |
5 |
flow cytometry |
5 |
fluorescent antibody technique |
5 |
follow-up studies |
5 |
forced expiratory volume - physiology |
5 |
gastroesophageal reflux |
5 |
gastrointestinal hemorrhage |
5 |
gene amplification |
5 |
genes, tumor suppressor |
5 |
helicobacter infections - drug therapy - pathology |
5 |
hippo signaling |
5 |
hmlh1 |
5 |
hydroxamic acids - pharmacology |
5 |
infant, newborn |
5 |
length |
5 |
li-cadherin |
5 |
liver neoplasms - diagnosis - etiology - genetics - surgery |
5 |
liver neoplasms - diagnosis - mortality |
5 |
liver transplantation - adverse effects |
5 |
living donors |
5 |
lymphokines - metabolism |
5 |
membrane proteins - genetics - metabolism |
5 |
metaplasia - metabolism |
5 |
microsatellite instability |
5 |
mutations |
5 |
muts homolog 2 protein |
5 |
nasopharyngeal neoplasms - metabolism |
5 |
neoplasm proteins - genetics |
5 |
neoplasm proteins - metabolism |
5 |
noncardiac chest pain |
5 |
non–vitamin k antagonist oral anticoagulants |
5 |
nsaid |
5 |
nuclear proteins |
5 |
nuclear proteins - analysis |
5 |
p53 |
5 |
papillotomy |
5 |
pilot projects |
5 |
polymerase chain reaction |
5 |
post‐colonoscopy colorectal cancer |
5 |
prisma |
5 |
prognostic marker |
5 |
promoter methylation |
5 |
propensity score |
5 |
protein synthesis inhibitors - pharmacology |
5 |
proteins - genetics |
5 |
quality of life |
5 |
questionnaires |
5 |
readmission |
5 |
real‐life |
5 |
renin |
5 |
respiratory diseases |
5 |
rna, viral - analysis |
5 |
roc curve |
5 |
rt-pcr |
5 |
sarcoma - diagnosis - etiology - genetics - surgery |
5 |
sars |
5 |
severity of illness index |
5 |
smoking - adverse effects |
5 |
stomach neoplasms - blood - diagnosis |
5 |
stomach neoplasms - diagnosis - genetics - mortality |
5 |
stomach neoplasms - genetics - pathology |
5 |
stomach neoplasms - genetics - pathology - virology |
5 |
stomach neoplasms - metabolism - pathology |
5 |
stroke |
5 |
surrogate |
5 |
tissue distribution |
5 |
transcription factors - analysis |
5 |
transcription factors - genetics |
5 |
transcription factors - metabolism |
5 |
transcription, genetic |
5 |
transplantation, homologous - adverse effects |
5 |
tumor markers, biological - genetics |
5 |
tumor recurrence |
5 |
tumor suppressor proteins |
5 |
tumour marker |
5 |
urea - analysis |
5 |
vascular endothelial growth factor a |
5 |
vascular endothelial growth factors |
5 |
viral persistence |
5 |
yes-associated protein |
5 |
1-phosphatidylinositol 3-kinase - genetics |
4 |
13c-urea breath test |
4 |
acp |
4 |
adenocarcinoma - etiology - genetics - metabolism |
4 |
adenocarcinoma - metabolism - pathology |
4 |
adenoma |
4 |
adp-ribosylation factors - metabolism |
4 |
adverse outcome |
4 |
age distribution |
4 |
ageaged |
4 |
albuminuria - physiopathology |
4 |
aldehyde reductase - genetics - metabolism |
4 |
algorithms |
4 |
allelic imbalance |
4 |
anti-infective agents - pharmacology - therapeutic use |
4 |
anti-ulcer agents - pharmacology - therapeutic use |
4 |
antibodies, bacterial - blood |
4 |
antibodies, bispecific |
4 |
antineoplastic combined chemotherapy protocols - therapeutic use |
4 |
antiplatelet |
4 |
antiplatelet drugs |
4 |
anxiety - psychology |
4 |
apoptosis - drug effects |
4 |
audiovisual aids |
4 |
axons - enzymology - pathology |
4 |
azacitidine - analogs & derivatives - therapeutic use |
4 |
base pair mismatch - genetics |
4 |
bax |
4 |
bcl-2-associated x protein |
4 |
beta-thalassemia - physiopathology |
4 |
bioinformatics |
4 |
biological markers - blood |
4 |
biopsy - instrumentation - methods |
4 |
bismuth |
4 |
blotting, southern |
4 |
bmi |
4 |
breathing exercises |
4 |
cadherins |
4 |
calcium channel blockers |
4 |
carcinoembryonic antigen |
4 |
carcinoma - genetics |
4 |
carcinoma - genetics - pathology - virology |
4 |
cardiology - education |
4 |
cardiovascular diseases - metabolism - physiopathology |
4 |
catch-up growth |
4 |
ccl |
4 |
cdx2 |
4 |
cell cycle - physiology |
4 |
cell division |
4 |
cell growth processes - physiology |
4 |
cell movement - genetics |
4 |
cell movement - physiology |
4 |
cell transformation, neoplastic |
4 |
cervical vertebrae |
4 |
chemokine (c-c motif) ligand |
4 |
chemokines, cc - genetics - immunology |
4 |
chi-square distribution |
4 |
child development |
4 |
ci |
4 |
circadian rhythm |
4 |
colorectal neoplasms |
4 |
colorectal neoplasms - genetics - pathology |
4 |
comprehension |
4 |
confidence interval |
4 |
continuous positive airway pressure |
4 |
crc patients |
4 |
cyclin-dependent kinase inhibitor p21 |
4 |
cysteine proteinase inhibitors - pharmacology |
4 |
depression - psychology |
4 |
dermatomyositis - etiology - therapy |
4 |
diabetic neuropathies - enzymology - genetics - physiopathology |
4 |
disease-free survival |
4 |
dna microarray |
4 |
dna mismatch repair - genetics |
4 |
dna modification methylases - antagonists & inhibitors |
4 |
dna primers - chemistry |
4 |
dna repair |
4 |
dna repair - genetics |
4 |
down-regulation - genetics |
4 |
doxycycline - pharmacology |
4 |
drug resistance |
4 |
drug synergism |
4 |
drug therapy, combination - therapeutic use |
4 |
drug use |
4 |
dyspepsia - pathology |
4 |
education, medical, undergraduate |
4 |
educational status |
4 |
endoscopy |
4 |
endoscopy, digestive system - instrumentation |
4 |
enzyme activation - drug effects |
4 |
enzyme inhibitors - therapeutic use |
4 |
epstein-barr virus |
4 |
equipment reuse |
4 |
exercise |
4 |
exercise therapy |
4 |
exome |
4 |
experimental design |
4 |
extracellular signal-regulated map kinases - antagonists & inhibitors - metabolism |
4 |
galactitol - metabolism |
4 |
galactosemias - enzymology - genetics - physiopathology |
4 |
gastric carcinoma |
4 |
gastric mucosa - physiology |
4 |
gastritis |
4 |
gene deletion |
4 |
gene expression regulation, neoplastic - immunology |
4 |
genes, ras |
4 |
genes, ras - genetics |
4 |
genes, tumor suppressor - genetics |
4 |
genetic predisposition to disease - genetics |
4 |
glioblastoma - genetics - metabolism - pathology |
4 |
glioma |
4 |
glutathione - metabolism |
4 |
gpi-linked proteins |
4 |
growth - physiology |
4 |
growth curve |
4 |
h pylori |
4 |
hazard ratio |
4 |
health economics |
4 |
health knowledge, attitudes, practice |
4 |
health status |
4 |
health surveys |
4 |
heart rate |
4 |
helicobacter |
4 |
helicobacter infections - complications - drug therapy - pathology |
4 |
helicobacter infections - complications - microbiology |
4 |
helicobacter pylori - immunology - isolation & purification |
4 |
helicobacter pylori - isolation & purification |
4 |
helicobacter pylori - treatment |
4 |
helicobacterpylori |
4 |
helix-loop-helix motifs |
4 |
herpesviridae infections - complications |
4 |
herpesvirus 4, human - isolation & purification |
4 |
herpesvirus 4, human - pathogenicity |
4 |
histone deacetylase inhibitors |
4 |
homeodomain proteins - genetics - metabolism |
4 |
hong kong chinese |
4 |
hpv vaccine |
4 |
hpv vaccine perception |
4 |
hpv vaccine questionnaire |
4 |
hpv vaccine survey |
4 |
hr |
4 |
human papillomavirus |
4 |
hydroxamic acids - therapeutic use |
4 |
hyperglycemia - enzymology - genetics - physiopathology |
4 |
hypertension - physiopathology - psychology - therapy - urine |
4 |
id4 |
4 |
ihc |
4 |
immortal time bias |
4 |
immunosuppressive agents - therapeutic use |
4 |
inhibitor of differentiation proteins |
4 |
insulin - metabolism |
4 |
insulin sensitivity |
4 |
karyotype |
4 |
latency interval |
4 |
loss of heterozygosity |
4 |
lupus erythematosus, systemic - epidemiology - genetics |
4 |
lymph node metastasis |
4 |
lymphatic metastasis - genetics |
4 |
macrophage migration-inhibitory factor |
4 |
macrophage migration-inhibitory factors - blood |
4 |
malignancy |
4 |
mannose-binding lectins |
4 |
map kinase signaling system |
4 |
matrix metalloproteinase |
4 |
membrane transport proteins |
4 |
metagenomics |
4 |
metronidazole - pharmacology - therapeutic use |
4 |
metronidazole - therapeutic use |
4 |
mice, inbred balb c |
4 |
microarray |
4 |
microbiome |
4 |
micrornas - physiology |
4 |
mmp |
4 |
mortality |
4 |
motor neuron disease - etiology - therapy |
4 |
mucosal immunity |
4 |
mutation - genetics |
4 |
myositis - etiology - therapy |
4 |
nasal continuous positive airway pressure |
4 |
nasopharyngeal neoplasms - complications |
4 |
neoplasm recurrence, local - complications - therapy |
4 |
neovascularization, pathologic |
4 |
nerve fibers, myelinated - enzymology - pathology |
4 |
nerve tissue proteins - biosynthesis - genetics - physiology |
4 |
nerve tissue proteins - genetics - metabolism |
4 |
neural conduction - genetics |
4 |
next generation sequencing |
4 |
nf-kappa b - physiology |
4 |
nonsteroidal anti-inflammatory drugs |
4 |
nuclear proteins - genetics |
4 |
nuclear proteins - genetics - metabolism |
4 |
obstructive sleep apnoea |
4 |
omeprazole - pharmacology - therapeutic use |
4 |
omeprazole - therapeutic use |
4 |
oral anticoagulant |
4 |
oxidative stress - genetics |
4 |
oxygen - metabolism |
4 |
papillomaviridae - immunology |
4 |
papillomavirus infections - prevention & control - virology |
4 |
papillomavirus vaccines |
4 |
paraneoplastic inflammatory myopathy |
4 |
paraneoplastic motor neuropathy |
4 |
paraneoplastic syndromes - etiology - therapy |
4 |
patient simulation |
4 |
pedigree |
4 |
peptic ulcer |
4 |
pharmacoepidemiology |
4 |
polymorphism, single-stranded conformational |
4 |
ppi |
4 |
precancerous conditions - metabolism |
4 |
prevention |
4 |
protein biosynthesis |
4 |
proto-oncogene proteins - metabolism |
4 |
proto-oncogene proteins b-raf - genetics |
4 |
proton pump inhibitors |
4 |
psychiatric status rating scales |
4 |
puberty, delayed |
4 |
qigong |
4 |
random allocation |
4 |
randomised controlled trial |
4 |
ranitidine - analogs & derivatives |
4 |
ras proteins - genetics |
4 |
receptors, prostaglandin e, ep2 subtype - physiology |
4 |
receptors, prostaglandin e, ep4 subtype - physiology |
4 |
receptors, transforming growth factor beta - genetics |
4 |
regression analysis |
4 |
renin - blood |
4 |
retrospective studies |
4 |
reverse-transcription polymerase chain reaction |
4 |
rna, messenger - analysis |
4 |
rna, messenger - biosynthesis |
4 |
rna, messenger - biosynthesis - genetics |
4 |
schwann cells - cytology - enzymology |
4 |
sensitivity and specificity |
4 |
sequence homology, amino acid |
4 |
sex distribution |
4 |
shock - metabolism - physiopathology |
4 |
sleep apnea, obstructive - metabolism - therapy |
4 |
specimen handling - instrumentation - methods - nursing |
4 |
ssc |
4 |
standard saline citrate |
4 |
statistics, nonparametric |
4 |
stomach neoplasms - blood - diagnosis - mortality |
4 |
stomach neoplasms - etiology |
4 |
stomach neoplasms - etiology - genetics - metabolism |
4 |
stomach neoplasms - genetics - metabolism - pathology |
4 |
stomach neoplasms - pathology |
4 |
stress, physiological - enzymology - genetics - physiopathology |
4 |
students, medical |
4 |
surgery |
4 |
t-lymphocytes - immunology |
4 |
tartrate-resistant acid phosphatase |
4 |
teaching - methods |
4 |
thinness |
4 |
thiopurines |
4 |
time trend |
4 |
tumor marker |
4 |
tumor virus infections - complications |
4 |
turner's syndrome |
4 |
tβrii |
4 |
up-regulation - drug effects |
4 |
up-regulation - genetics |
4 |
uterine cervical neoplasms - prevention & control - virology |
4 |
weight |
4 |
3-month overall survival |
3 |
5-ht3 receptor antagonist |
3 |
adenocarcinoma - complications - microbiology |
3 |
adenocarcinoma - drug therapy - enzymology - pathology |
3 |
adenocarcinoma - enzymology - pathology |
3 |
adenocarcinoma - ethnology - genetics |
3 |
adenocarcinoma - genetics - pathology |
3 |
adenoma - enzymology - pathology |
3 |
adenoma - etiology - pathology |
3 |
adenomatous polyposis coli - genetics - pathology |
3 |
advanced liver cancer prognostic system |
3 |
age |
3 |
alternative splicing |
3 |
amoxicillin-potassium clavulanate combination - therapeutic use |
3 |
analgesia |
3 |
angiogenesis |
3 |
angiopoietin-1 |
3 |
angiopoietin-2 |
3 |
angiopoietins |
3 |
anti-bacterial agents |
3 |
anti-bacterial agents - therapeutic use |
3 |
anti-infective agents - therapeutic use |
3 |
anti-obesity agents - adverse effects - pharmacokinetics - pharmacology |
3 |
antiemetic |
3 |
antineoplastic combined chemotherapy protocols - administration & dosage - therapeutic use |
3 |
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
3 |
apoptosis - drug effects - physiology |
3 |
apoptotic cells |
3 |
area under curve |
3 |
artificial ventilation |
3 |
ascaris lumbricoides - isolation & purification |
3 |
asia - epidemiology |
3 |
asian continental ancestry group - genetics |
3 |
astrocytoma - blood supply - genetics |
3 |
astrocytoma - blood supply - metabolism - pathology |
3 |
astrocytoma - metabolism - pathology |
3 |
autoimmunity |
3 |
bacterial artificial chromosome |
3 |
bar |
3 |
bcl-2 |
3 |
bcl-6 |
3 |
bile - chemistry |
3 |
bile acids and salts - chemistry |
3 |
bioimpedance |
3 |
bismuth - therapeutic use |
3 |
blotting, northern |
3 |
bone density - physiology |
3 |
bone mass density |
3 |
brain neoplasms - blood supply - genetics |
3 |
brain neoplasms - blood supply - metabolism - pathology |
3 |
brain neoplasms - drug therapy - pathology |
3 |
brain neoplasms - epidemiology - metabolism - pathology |
3 |
brain neoplasms - genetics - pathology |
3 |
brain neoplasms - metabolism - pathology |
3 |
bronchiectasis - immunology - microbiology |
3 |
bungarotoxins - pharmacology |
3 |
c-reactive protein |
3 |
c-reactive protein - metabolism |
3 |
cancer |
3 |
cancer cell |
3 |
carboplatin |
3 |
carcinogens - toxicity |
3 |
carcinoma - genetics - metabolism - pathology |
3 |
carcinoma - metabolism - pathology - virology |
3 |
carcinoma - metabolism - virology |
3 |
carcinoma - pathology - virology |
3 |
carcinoma, non-small-cell lung - blood supply - metabolism |
3 |
carcinoma, non-small-cell lung - metabolism |
3 |
carcinoma, non-small-cell lung - virology |
3 |
carcinoma, squamous cell - ethnology - pathology - virology |
3 |
carcinoma, squamous cell - metabolism - pathology - virology |
3 |
carcinoma, squamous cell - parasitology |
3 |
carcinoma, squamous cell - virology |
3 |
carrier proteins - blood |
3 |
caspase 7 |
3 |
caspases |
3 |
caucasian |
3 |
cell cycle - drug effects |
3 |
cell cycle proteins - biosynthesis - genetics |
3 |
cell proliferation - drug effects |
3 |
cell transformation, neoplastic - metabolism |
3 |
central nervous system neoplasms - chemistry - genetics - pathology |
3 |
cerebellar neoplasms - blood supply - genetics |
3 |
cerebrovascular accident |
3 |
chemicals and cas registry numbers |
3 |
chemokine ccl2 - biosynthesis |
3 |
chemokine ccl2 - metabolism |
3 |
childhood |
3 |
childhood diabetes |
3 |
cholesterol - metabolism |
3 |
choristoma-complications |
3 |
chromosomal instability |
3 |
chromosome aberrations |
3 |
chromosomes, human, pair 14 - genetics - metabolism |
3 |
chromosomes, human, pair 9 - genetics |
3 |
chronic disease |
3 |
chronic obstructive pulmonary disease |
3 |
clinical trials. |
3 |
clonality |
3 |
colitis, ulcerative - etiology - pathology |
3 |
colon |
3 |
colon - metabolism - pathology |
3 |
colon carcinoma |
3 |
colonic neoplasms - enzymology - pathology |
3 |
colonic neoplasms - etiology - pathology |
3 |
colonic neoplasms - metabolism |
3 |
colorectal neoplasms - diagnosis - ethnology |
3 |
colorectal neoplasms - ethnology - genetics |
3 |
colorectal neoplasms - genetics - metabolism - pathology |
3 |
colorectal neoplasms, hereditary nonpolyposis - genetics |
3 |
combigem |
3 |
combination therapy |
3 |
combinatorial genetics |
3 |
comparative genomic hybridization |
3 |
complementary dna |
3 |
coronavirus |
3 |
cox-2 |
3 |
crispr |
3 |
cyclin d1 - metabolism |
3 |
cyclin-dependent kinase inhibitor p27 |
3 |
cyclins - biosynthesis - genetics |
3 |
cyclooxygenase 2 - drug effects - metabolism |
3 |
cyclosporine - therapeutic use |
3 |
cystadenoma, papillary - complications - metabolism - pathology |
3 |
cysteine endopeptidases - physiology |
3 |
data collection |
3 |
dendritic cells |
3 |
development |
3 |
dexamethasone |
3 |
dexamethasone - administration & dosage |
3 |
dextran sulfate - toxicity |
3 |
diabetes-insipidus-etiology |
3 |
diagnosis, differential |
3 |
dinoprostone - metabolism |
3 |
diploidy |
3 |
disease outbreaks |
3 |
dna fragmentation |
3 |
dna, complementary - chemistry - isolation & purification - metabolism |
3 |
dna, neoplasm - analysis |
3 |
dna, satellite - genetics |
3 |
drug side effect |
3 |
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
dual-energy x-ray absorptiometry |
3 |
dyspepsia - microbiology |
3 |
ebna2 |
3 |
ebv |
3 |
ebv proteins |
3 |
electric impedance |
3 |
endothelial growth factors - biosynthesis |
3 |
endothelial growth factors - genetics - metabolism |
3 |
endothelial growth factors - genetics - physiology |
3 |
energy intake |
3 |
enzyme inhibitors - adverse effects - pharmacokinetics - pharmacology |
3 |
ependymoma |
3 |
ependymoma - blood supply - metabolism - pathology |
3 |
epididymal cystadenoma |
3 |
epididymis - pathology |
3 |
epithelial cells - drug effects - enzymology - pathology |
3 |
epithelial cells - metabolism |
3 |
epstein-barr virus infections - complications |
3 |
european continental ancestry group |
3 |
european continental ancestry group - genetics |
3 |
eye neoplasms - pathology - virology |
3 |
fetal blood - chemistry |
3 |
flt-1 |
3 |
forced expiratory volume |
3 |
founder effect |
3 |
functional residual capacity |
3 |
gallbladder - drug effects - physiology |
3 |
gastric dysplasia |
3 |
gastric mucosa |
3 |
gastric mucosa - pathology |
3 |
gastroscopy |
3 |
gene expression regulation |
3 |
gene expression regulation - drug effects |
3 |
genes, p53 |
3 |
germ cell tumour |
3 |
germ-line mutation |
3 |
germline mutation |
3 |
glioblastoma |
3 |
glioblastoma - genetics - pathology |
3 |
glioblastoma - metabolism - pathology |
3 |
glioma - chemistry - genetics - pathology |
3 |
glioma - metabolism - pathology |
3 |
great britain - epidemiology |
3 |
growth |
3 |
h2ra |
3 |
haplotypes - genetics |
3 |
head and neck neoplasms - metabolism - virology |
3 |
healthcare dataset |
3 |
height |
3 |
helicobacter infections - complications - drug therapy |
3 |
helicobacter infections - diagnosis |
3 |
helicobacter infections - diagnosis - immunology |
3 |
helicobacter infections - drug therapy |
3 |
helicobacter infections - epidemiology |
3 |
helicobacter infections - metabolism |
3 |
helicobacter pylori - isolation and purification |
3 |
hemangioblastoma |
3 |
herpesviridae infections |
3 |
herpesviridae infections - complications - pathology |
3 |
herpesvirus 4, human |
3 |
herpesvirus 4, human - genetics |
3 |
herpesvirus 4, human - genetics - isolation & purification - metabolism |
3 |
herpesvirus 4, human - immunology - isolation & purification |
3 |
high-throughput screening |
3 |
hndrg2 |
3 |
hnpcc |
3 |
hnpcc syndrome |
3 |
hong kong - ethnology |
3 |
hospitalization - statistics & numerical data |
3 |
human growth hormone - blood |
3 |
immune function |
3 |
infancy |
3 |
infant, newborn - physiology |
3 |
infection |
3 |
inflammation |
3 |
insulin-like growth factor binding protein 3 - blood |
3 |
insulin-like growth factor i - metabolism |
3 |
intercellular signaling peptides and proteins - metabolism |
3 |
interleukin-1beta - genetics |
3 |
interleukin-6 |
3 |
interleukin-8 |
3 |
intestinal mucosa - enzymology - pathology |
3 |
intracranial |
3 |
intragenic deletion |
3 |
intrauterine growth retardation |
3 |
jumonji domain-containing histone demethylases |
3 |
kdr |
3 |
lacrimal apparatus - pathology |
3 |
lacrimal apparatus diseases - pathology |
3 |
lacrimal sac |
3 |
lactones - adverse effects - pharmacokinetics - pharmacology |
3 |
large intestine |
3 |
leukemia, lymphoid - complications - drug therapy |
3 |
leukemia, myelogenous, chronic, bcr-abl positive - pathology |
3 |
leupeptins - pharmacology |
3 |
lipase - antagonists & inhibitors |
3 |
lipids - analysis |
3 |
lmp-1 |
3 |
lung |
3 |
lung carcinoma |
3 |
lung disease burden |
3 |
lung function |
3 |
lung neoplasms - blood supply - metabolism |
3 |
lung neoplasms - metabolism |
3 |
lung neoplasms - metabolism - pathology - virology |
3 |
lung neoplasms - virology |
3 |
lung volume measurements |
3 |
lupus |
3 |
lymph-node metastasis |
3 |
lymphoepithelial carcinoma |
3 |
lymphoepithelioma |
3 |
lymphoepithelioma-like carcinoma |
3 |
lymphoid tissue - pathology - virology |
3 |
lymphokines - biosynthesis |
3 |
lymphokines - genetics - metabolism |
3 |
lymphokines - genetics - physiology |
3 |
lymphoma - epidemiology - metabolism - pathology |
3 |
lymphoma, b-cell, marginal zone - complications - microbiology |
3 |
lysozyme |
3 |
macrophage |
3 |
macrophages - pathology |
3 |
magnifying endoscopy |
3 |
mannose-binding protein |
3 |
mass screening - methods |
3 |
maximal expiratory flow rate |
3 |
membrane glycoproteins - biosynthesis |
3 |
meta-analysis |
3 |
metoclopramide |
3 |
microglia |
3 |
mismatch repair gene mutation |
3 |
mitoxantrone - administration & dosage |
3 |
monocyte chemoattractant protein- 1 |
3 |
monocyte chemoattractant protein-1 |
3 |
monotherapy |
3 |
multienzyme complexes - antagonists & inhibitors - physiology |
3 |
multivariate analysis |
3 |
muramidase - biosynthesis - genetics |
3 |
muscle proteins |
3 |
nchs |
3 |
necrotic cells |
3 |
neoplasm proteins - biosynthesis |
3 |
neoplasms - enzymology - genetics |
3 |
neoplasms - epidemiology - genetics - pathology - virology |
3 |
neoplasms, second primary - genetics - pathology |
3 |
neoplastic syndromes, hereditary - genetics - pathology |
3 |
neovascularization, pathologic - etiology |
3 |
neovascularization, pathologic - metabolism |
3 |
nerve degeneration - etiology |
3 |
nerve tissue proteins - biosynthesis |
3 |
nicotine |
3 |
nicotine - toxicity |
3 |
nicotinic acetylcholine receptor |
3 |
nitrosamines - toxicity |
3 |
nnk |
3 |
non-small cell lung carcinoma |
3 |
nose neoplasms - metabolism - pathology - virology |
3 |
nucleic acid hybridization |
3 |
nutritional status |
3 |
obesity - drug therapy - metabolism |
3 |
oligodendroglioma |
3 |
oligodendroglioma - blood supply - metabolism - pathology |
3 |
oncogene proteins - genetics |
3 |
oncogene proteins, viral - genetics |
3 |
organ size |
3 |
organ specificity |
3 |
osteolysis - pathology |
3 |
osteoporosis |
3 |
osteoporosis - diagnosis - physiopathology |
3 |
ovarian cancer |
3 |
ovarian neoplasms - drug therapy - immunology |
3 |
oxidoreductases, n-demethylating - genetics |
3 |
p38 mitogen-activated protein kinases - drug effects - metabolism |
3 |
p53 mutation |
3 |
paraffin embedding |
3 |
paranasal sinus neoplasms - metabolism - pathology - virology |
3 |
paraneoplastic polyneuropathy - etiology |
3 |
parecoxib |
3 |
paresthesia - etiology |
3 |
parietal lobe |
3 |
phenotype |
3 |
pilocytic astrocytoma |
3 |
pineal gland |
3 |
pituitary-gland |
3 |
plethysmography |
3 |
ploidies |
3 |
postmenopause - physiology |
3 |
postnatal growth |
3 |
precancerous conditions - epidemiology - microbiology - pathology - prevention & control |
3 |
precancerous conditions - genetics - metabolism - pathology |
3 |
prematurity |
3 |
preterm infants |
3 |
primary brain lymphoma |
3 |
prognostic score system |
3 |
propranolol - pharmacology |
3 |
proteasome endopeptidase complex |
3 |
proto-oncogene proteins |
3 |
proto-oncogene proteins - biosynthesis - genetics |
3 |
proto-oncogene proteins - genetics - metabolism |
3 |
proto-oncogene proteins b-raf |
3 |
proto-oncogene proteins c-bcl-2 - metabolism |
3 |
proto-oncogene proteins c-bcl-6 |
3 |
proton pumps - antagonists & inhibitors |
3 |
pulmonary disease, chronic obstructive - blood - physiopathology |
3 |
pyloric antrum - pathology |
3 |
ranitidine - analogs & derivatives - therapeutic use |
3 |
receptor protein-tyrosine kinases - biosynthesis |
3 |
receptor protein-tyrosine kinases - metabolism |
3 |
receptor tyrosine kinase tie2 |
3 |
receptor, epidermal growth factor - genetics |
3 |
receptors, adrenergic, beta - drug effects - metabolism |
3 |
receptors, growth factor - genetics - physiology |
3 |
receptors, growth factor - metabolism |
3 |
receptors, mitogen - genetics - physiology |
3 |
receptors, nicotinic - drug effects - metabolism |
3 |
receptors, vascular endothelial growth factor |
3 |
rectal cancer |
3 |
reproducibility of results |
3 |
research design |
3 |
residual volume |
3 |
respiratory tract diseases - epidemiology - mortality |
3 |
rna - analysis |
3 |
rna, neoplasm - genetics - metabolism |
3 |
rna, viral - metabolism |
3 |
salivary gland |
3 |
sella-turcica |
3 |
sequence deletion |
3 |
sex factors |
3 |
signal transduction |
3 |
signal transduction - drug effects |
3 |
skull-neoplasms-complications |
3 |
smoking - blood |
3 |
spinal cord neoplasms - blood supply - genetics |
3 |
spirometry |
3 |
staging |
3 |
stomach neoplasms - complications - microbiology |
3 |
stomach neoplasms - drug therapy - enzymology - pathology |
3 |
stomach neoplasms - epidemiology - microbiology - pathology - prevention & control |
3 |
stomach neoplasms - metabolism |
3 |
stomach neoplasms - metabolism - virology |
3 |